The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for research

Violette, C. J., Agarwal, R., Mandelbaum, R. S., González, J. L., Hong, K. M., Roman, L. D., Klar, M., Wright, J. D., Paulson, R. J., Obermair, A., & Matsuo, K. (2023). The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for research. Expert Review of Anticancer Therapy, 23(4), 385–395. https://doi.org/10.1080/14737140.2023.2194636
Authors:
Caroline J Violette
Ravi Agarwal
Rachel S Mandelbaum
José L González
Kurt M Hong
Lynda D Roman
Maximilan Klar
Jason D Wright
Richard J Paulson
Andreas Obermair
Koji Matsuo
Affiliated Authors:
Jason D Wright
Columbia Affiliation:
Subjects:
Diabetes Mellitus, Type 2 (MeSH)
Fertility Preservation (MeSH)
Polycystic Ovary Syndrome (MeSH)
Endometrial Neoplasms (MeSH)
Author Keywords:
endometrial cancer
glp-1ra
endometrial intraepithelial neoplasm
fertility sparing
glucagon-like peptide 1 receptor agonist
insulin resistance
obesity
polycystic ovary syndrome
progestin therapy
type-2 diabetes
elink
Publication Type:
Article
Unique ID:
10.1080/14737140.2023.2194636
PMID:
36944434
DOI:
10.1080/14737140.2023.2194636
Journal:
Expert Review of Anticancer Therapy
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: